Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)

Carregando...
Imagem de Miniatura
Citações na Scopus
46
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER ESPANA
Citação
ANNALS OF HEPATOLOGY, v.18, n.3, p.416-421, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Genetic predisposition, the intestinal microbiota (IM) and environmental factors, such as sedentary lifestyle and inadequate diet, should be considered as critical factors for the development of nonalcoholic fatty liver disease (NAFLD). Recently, some studies have demonstrated an association between dysbiosis and NAFLD; however, the exact mechanisms that lead to intestinal membrane damage, bacterial translocation and inflammation are not well elucidated. Due to the relevance of this theme, the IM and its metabolites have received special attention in recent years in an attempt to better understand the mechanisms related to the prevention, physiopathology, and treatment of NAFLD. In this paper, we provide a review of the human IM and its role in diet, obesity, and the development/progression of NAFLD/NASH, as well as the use of prebiotics and probiotics in the modulation of IM. (C) 2019 Fundacion Clinica Medica Sur, A.C.
Palavras-chave
NAFLD, NASH, Intestinal microbiota, Dysbiosis, Probiotics
Referências
  1. Abu Shanab A, 2011, DIGEST DIS SCI, V56, P1524, DOI 10.1007/s10620-010-1447-3
  2. Angelico F, 2005, J CLIN ENDOCR METAB, V90, P1578, DOI 10.1210/jc.2004-1024
  3. Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101
  4. Bajzer M, 2006, NATURE, V444, P1009, DOI 10.1038/4441009a
  5. Betrapally NS, 2016, GASTROENTEROLOGY, V150, P1745, DOI 10.1053/j.gastro.2016.02.073
  6. Bindels LB, 2012, BRIT J CANCER, V107, P1337, DOI 10.1038/bjc.2012.409
  7. Blaut Michael, 2002, European Journal of Nutrition, V41, P11
  8. Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356
  9. Boursier J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004559
  10. Boutagy NE, 2016, BIOCHIMIE, V124, P11, DOI 10.1016/j.biochi.2015.06.020
  11. Bradford V, 2014, HEPATIC MED-EVID RES, V6, P1, DOI [10.2147/HMER.S34472, 10.2147/1MER.S34472]
  12. Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006
  13. Cani PD, 2008, PATHOL BIOL, V56, P305, DOI 10.1016/j.patbio.2007.09.008
  14. Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491
  15. Cho MS, 2018, J MICROBIOL, V56, P855, DOI 10.1007/s12275-018-8346-2
  16. Da Silva HE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19753-9
  17. da Silva ST, 2013, NUTR HOSP, V28, P1039, DOI 10.3305/nh.2013.28.4.6525
  18. Day C P, 2002, J Gastroenterol Hepatol, V17 Suppl 3, pS377, DOI 10.1046/j.1440-1746.17.s3.31.x
  19. de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010
  20. Donato KA, 2010, MICROBIOL-SGM, V156, P3288, DOI 10.1099/mic.0.040139-0
  21. Duarte SMB, 2018, NUTR METAB CARDIOVAS, V28, P369, DOI 10.1016/j.numecd.2017.10.014
  22. Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103
  23. Engstler AJ, 2016, GUT, V65, P1564, DOI 10.1136/gutjnl-2014-308379
  24. Eslamparast T, 2014, AM J CLIN NUTR, V99, P535, DOI 10.3945/ajcn.113.068890
  25. Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973
  26. Fasano A, 2008, AM J PATHOL, V173, P1243, DOI 10.2353/ajpath.2008.080192
  27. Cano PG, 2013, OBESITY, V21, P2310, DOI 10.1002/oby.20330
  28. Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15
  29. Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042
  30. Jandhyala SM, 2015, WORLD J GASTROENTERO, V21, P8787, DOI 10.3748/wjg.v21.i29.8787
  31. Karagiannides I, 2007, CURR OPIN GASTROEN, V23, P661, DOI 10.1097/MOG.0b013e3282c8c8d3
  32. Kashyap PC, 2013, GASTROENTEROLOGY, V144, P967, DOI 10.1053/j.gastro.2013.01.047
  33. Kobyliak N, 2018, J GASTROINTEST LIVER, V27, P41, DOI 10.15403/jgld.2014.1121.271.kby
  34. Lakhani SV, 2008, NUTR RES, V28, P293, DOI 10.1016/j.nutres.2008.03.002
  35. Leung C, 2016, NAT REV GASTRO HEPAT, V13, P412, DOI 10.1038/nrgastro.2016.85
  36. Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751
  37. Loomba R, 2017, CELL METAB, V25, P1054, DOI 10.1016/j.cmet.2017.04.001
  38. Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025
  39. Machado MV, 2012, ANN HEPATOL, V11, P440, DOI 10.1016/S1665-2681(19)31457-7
  40. Machado MV, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040481
  41. Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106
  42. Malaguarnera M, 2012, DIGEST DIS SCI, V57, P545, DOI 10.1007/s10620-011-1887-4
  43. Manoharan I, 2016, J IMMUNOL, V196, P4739, DOI 10.4049/jimmunol.1501489
  44. Madrid AM, 2011, DIGEST DIS SCI, V56, P155, DOI 10.1007/s10620-010-1239-9
  45. Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848
  46. Mofidi F, 2017, BRIT J NUTR, V117, P662, DOI 10.1017/S0007114517000204
  47. Mokhtari Z, 2017, ADV NUTR, V8, P240, DOI 10.3945/an.116.013151
  48. Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505
  49. Paolella G, 2014, WORLD J GASTROENTERO, V20, P15518, DOI 10.3748/wjg.v20.i42.15518
  50. Park JS, 2013, PEDIATR GASTROENTERO, V16, P22, DOI 10.5223/pghn.2013.16.1.22
  51. Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646
  52. Pereira DIA, 2002, CRIT REV BIOCHEM MOL, V37, P259, DOI 10.1080/10409230290771519
  53. Powrie F, 2004, ANN NY ACAD SCI, V1029, P132, DOI 10.1196/annals.1309.030
  54. Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363
  55. Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176
  56. Scheppach W, 2004, CURR OPIN CLIN NUTR, V7, P563, DOI 10.1097/00075197-200409000-00009
  57. Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643
  58. Scott KP, 2013, PHARMACOL RES, V69, P52, DOI 10.1016/j.phrs.2012.10.020
  59. Sharma Vishal, 2013, Perm J, V17, P62, DOI 10.7812/TPP/12-144
  60. Sheng LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01576-9
  61. Shin HS, 2010, ARCH PHARM RES, V33, P1425, DOI 10.1007/s12272-010-0917-7
  62. Soares JB, 2010, HEPATOL INT, V4, P659, DOI 10.1007/s12072-010-9219-x
  63. Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105
  64. Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049
  65. Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122
  66. Tagliari E, 2017, ABCD-ARQ BRAS CIR DI, V30, P211, DOI 10.1590/0102-6720201700030011
  67. Tarantino G, 2015, FUTURE MICROBIOL, V10, P889, DOI [10.2217/FMB.15.13, 10.2217/fmb.15.13]
  68. Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109
  69. Trenell MI, 2015, J HEPATOL, V63, P1064, DOI 10.1016/j.jhep.2015.08.009
  70. Trottier J, 2011, CLIN PHARMACOL THER, V90, P279, DOI 10.1038/clpt.2011.124
  71. Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322
  72. Usman, 2000, J DAIRY SCI, V83, P1705, DOI 10.3168/jds.S0022-0302(00)75039-9
  73. Verdam FJ, 2011, J CLIN GASTROENTEROL, V45, P149, DOI 10.1097/MCG.0b013e3181e12c24
  74. Volynets V, 2012, DIGEST DIS SCI, V57, P1932, DOI 10.1007/s10620-012-2112-9
  75. Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118
  76. Wang RR, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01602
  77. Wigg AJ, 2001, GUT, V48, P206, DOI 10.1136/gut.48.2.206
  78. Wong VWS, 2013, ANN HEPATOL, V12, P256, DOI 10.1016/S1665-2681(19)31364-X
  79. Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100
  80. Zhu LX, 2016, GUT, V65, P1232, DOI 10.1136/gutjnl-2016-311571
  81. Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093